Isentio News

25.06.2012
RipSeq Single version 5.0 now released
The main update is the introduction of Presets, which will make it much easier to run different gene targets. Presets are preferred settings for individual gene targets, e.g. for ITS, 16S, rpoB, etc., that are saved in individual folders. All created subfolder will then automatically be run with these preferred settings. This includes the default Database to return to after looking at the detailed results for a sample. We have also enhanced the processing to speed up approving, rejecting, and adding notes to references, there are additional settings to allow for more control of how results are interpreted and we have improved the result report to include more information.
Press release (PDF)

14.12.2011
Isentio is granted NOK 2.6M to develop tools for diagnosis of fungal infections
Isentio AS has been awarded a grant of NOK 2.6M from Innovation Norway to develop a sequence based analysis tool for the diagnosis of fungal infections. ARUP Laboratories, Salt Lake City, Utah, USA will be a partner in this project.
Press release (PDF)

08.11.2011
Isentio and Haukeland University Hospital initiate brain abscess study using RipSeq(R) Mixed
Haukeland University Hospital, Bergen, Norway is heading up a national, multi-center study on bacterial brain abscesses, involving all Neurosurgical clinics in Norway. The bacterial content of these important clinical specimens will be analyzed with broad-range amplification of the bacterial 16S rRNA gene followed by DNA sequencing for identification. To solve the problems related to poly-bacterial samples, the RipSeq(R) Mixed software from Isentio AS will be used.
Press release (PDF)

21.03.2011
Isentio AS is expanding and opens office in Silicon Valley, USA
The new office of Isentio AS in Sunnyvale, California is a significant step in the company’s strategy to grow globally. As a fast growing life science software company, this presence in the innovative environment of Silicon Valley, with access to key resources and customers, is crucial for the company to meet its objectives to make RipSeq® the leading DNA analysis tool for pathogen identification.
Press release (PDF)

03.03.2011
RipSeq used for the detection of hybrid plants and their parental species (by Univ. of Turku, Finland).
In his thesis RipSeq Mixed was used instead of laborious and expensive sub-cloning, to detect parental copies of hybrid aquarium plants. The publication is a good example of the flexibility of the RipSeq software, how you build your own databases and how RipSeq provides both accurate information and saves valuable time and money.
Watery varieties: Aquarium plant diversity from aesthetic, commercial and systematic perspectives.  
"Ornamental plants: Types, Cultivation and Nutrition". ISBN: 978-1-61761-736-2 2011.
PDF-version here  

31.01.2011
Richard Lagnered has joined iSentio as Key Account Manager, Europe.
Richard has a M.Sci in Molecular biology from the University of Gothenburg, Sweden. He wrote his Master Thesis at the Lundberg Laboratory, Department of Microbiology. Richard will be based in Gothenburg and mainly focus on supporting our European efforts. As iSentio already has several university hospitals in Sweden using the RipSeq software application, we see the strengthening of our presence in Sweden as a benefit as well.

13.12.2010
1.5 million USD in new funding & new chairman of the board to Isentio AS
Isentio AS has raised 1.5 million USD in new funding from new and existing investors. The funding will be used to grow sales, marketing and support, as well as enable the company to accelerate the development of new application areas.
Press release (PDF)
Pressemelding (Norwegian) (PDF)

17.06.2010
Isentio featured in Finansavisen - The Norwegian Financial Daily
Isentio is portrayed in a feature article about the company and the company’s RipSeq® software product.
Page 1 (PDF)
Page 2 (PDF)

01.11.2009
Second article covering the RipSeq-method and clinical cases has been published in Journal of Clinical Microbiology - describing the clinical relevance of using RipSeq® for interpretation of mixed DNA chromatograms in clinical specimens.
Direct 16S rDNA sequencing from clinical specimens with special focus on poly-bacterial samples and interpretation of mixed DNA chromatograms
Øyvind Kommedal, Kristine Kvello, Rune Skjåstad, Nina Langeland, and Harald G. Wiker
Isentio article published in JCM Nov. 2009

18.08.2009
Isentio received a 1.5 MNOK internationalization grant from NORINT
The Confederation of Norwegian Enterprise's Foundation for Internationalization granted Isentio 1.5 MNOK for use in the companys efforts in further expanding its business into new international markets.
NHO
NORINT

22.05.2009
Isentio finalized a capital increase
Isentio is happy to announce that a capital increase of NOK 5.5 mill has been finalized. This is the first capital increase of since the foundation of the company in 2005.

21.05.2009
Isentio attended the ASM conference May 2009
Isentio attended the ASM 2009 conference in Philadelphia, USA. Lots of interest in our RipSeq product!

19.05.2009
Isentio attended the ECCMID conference in May 2009
Isentio attended the ECCMID 2009 conference in Helsinki, Finland. Europe is ready for the RipSeq product!

04.12.2008
Isentio wins the prestigious Reodor price for the best invention of the year
Isentio was awarded the price by Innovation Norway for the work on developing an new, fast and accurate bacterial identification method.  Read more about the price by following the links below:
NRK Nett-tv
Euroinvestor
BA News

19.10.2008
First study with ARUP Labs was presented at ICAAC 2008
ARUP Labs presented a poster in regards to their testing of the RipSeq Dual Loci method at the ICAAC 2008 conference. 

30.09.2008
First article covering the RipSeq-method has been published in Journal of Clinical Microbiology
Isentio's first article has already been published online on the Journal of Clinical Microbiology website.
Øyvind Kommedal, Bjarte Karlsen and Øystein F. Sæbø
Isentio article published in JCM Sept. 2008